Thursday, September 17, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Researchcerebrolysinstrokethrombectomycase report

Case report describes cerebrolysin after thrombectomy in 88-year-old stroke patient

Deficits resolved within 24 hours after three 30 mL daily doses were added to tenecteplase and mechanical thrombectomy, with no hemorrhagic transformation.

PR
By Priya Raman · Science Reporter

The wire

  1. 01The patient presented two hours after right hemiparesis and aphasia from an M2 left middle cerebral artery occlusion, received tenecteplase and thrombectomy with complete reperfusion, then adjunctive cerebrolysin 30 mL/day.
  2. 02Cerebrolysin is tracked by readers following neuropeptide preparations, and the report shows how clinicians weigh existing randomized and observational signals in individual decisions.
  3. 03The authors state explicitly that the report is not intended to establish efficacy; this is a single patient, and cerebrolysin was stopped after three doses.

From the source

Very Early Short-Course Cerebrolysin After Tenecteplase and Mechanical Thrombectomy: A Case Report

Case reports in neurological medicine · 2026 · Ziąbska H, Kobayashi A, Karliński M et al.

Read at pubmed.ncbi.nlm.nih.gov